In summary, T1 mapping on gadoxetic acid-enhanced MRI combined with Diffusion-weighted Imaging and AFP can help predict the CK19 expression status in HCC, which is expected to provide important guiding value for the subsequent treatment and prognostic assessment of HCC patients. The gene discussed is AFP; the disease is hepatocellular carcinoma.